ACTRN12619000791134终止1 期
A pilot trial of Exendin PET scanning in metastatic castrate resistant prostate cancer to demonstrate GLP1 receptor positive disease
Mark S Stein Pty Ltd0 个研究点目标入组 4 人开始时间: 2019年5月28日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 发起方
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •1) Metastatic castrate resistant prostate cancer (mCRPC)
- •2) A history of radical prostatectomy
- •3) More than one lesion on a PSMA PET scan performed in The Department of Cancer Imaging of The Peter MacCallum Cancer Centre, Melbourne, Australia
排除标准
- •Date of most recent PSMA PET scan more than 2 weeks ago
- •Known allergy or adverse reaction to Exenatide, other GLP-1 agonist or meta-Cresol
- •Creatinine clearance less than 30mL/minute and/or dialysis dependent renal failure
- •Type 1 diabetes
- •Severe gastrointestinal disease
- •Use of warfarin
- •Past history of pancreatitis
- •New York Heart Association Class IV dyspnoea
- •Intercurrent severe depression
- •Factors that would make it impractical to have radioactive urine
- •Variables that in the opinion of a member of the research team preclude the opportunity for informed consent and/or adherence to study protocol by a potential participant.
研究者
相似试验
招募中
2 期
Exendin PET/CT for imaging of paragangliomas10014713ParagangliomaNL-OMON50901ucleaire geneeskunde en radiologie10
已完成
1 期
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancerJPRN-UMIN000015356niversity of Tsukuba15
尚未招募
Unknown
[F-18]NaF-PET for bone imagingmetastatic bone tumorPET, bone meta.JPRN-jRCT2052230066Okazawa Hidehiko23
进行中（未招募）
1 期
Phase II trial: PET/CT for staging advanced and localized oral and oropharyngeal cancerEUCTR2016-002360-14-DKRigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET90
Unknown
早期 1 期
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of NesidioblastosisNesidioblastosisInsulinomaNCT02560376Peking Union Medical College Hospital100